Targeting Innate Immunity in Cancer Therapy

The majority of current cancer immunotherapy strategies target and potentiate antitumor adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited to a fraction of patients within a subset of tumor types, with an aggregate response rate of approximately 20% to date a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rameshbabu, Srikrishnan, Labadie, Brian W., Argulian, Anna, Patnaik, Akash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916062/
https://www.ncbi.nlm.nih.gov/pubmed/33572196
http://dx.doi.org/10.3390/vaccines9020138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916062/
https://www.ncbi.nlm.nih.gov/pubmed/33572196
http://dx.doi.org/10.3390/vaccines9020138

Ejemplares similares